Anti-Tumor Immunity
Showing 1 - 25 of >10,000
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Pancreatic Cancer Trial in Guangzhou (NanoKnife LEDC System)
Completed
- Pancreatic Cancer
- NanoKnife LEDC System
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021
Patients With Cancer Undergoing Radiation Therapy
Terminated
- Malignant Neoplasm
- cytology specimen collection procedure
- laboratory biomarker analysis
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Aug 15, 2022
Advanced Cancer Trial in Villejuif (Ipilimumab, Nivolumab, Tilsotolimod)
Active, not recruiting
- Advanced Cancer
- Ipilimumab
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Jul 21, 2021
Breast Cancer Trial in United States (Nivolumab, Ipilimumab, Nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Nivolumab
- +2 more
-
Los Angeles, California
- +7 more
Dec 2, 2021
Immunity Factors in Cancer Colon Patients Trial in Assuit (thoracic epidural)
Completed
- Immunity Factors in Cancer Colon Patients
- thoracic epidural
-
Assuit, EgyptSouth Egypt Cancer Institute
Aug 19, 2020
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New
Recruiting
- Mantle-cell Lymphoma
- B Cell Chronic Lymphocytic Leukemia
-
Monza, MB, ItalyAndrea Aroldi
May 24, 2023
Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant
Completed
- Solid Tumor
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
- Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
- (no location specified)
Jun 8, 2023
Histological or Cytological Diagnosis of Pancreatic Carcinoma Trial in Philadelphia (Radiation therapy)
Completed
- Histological or Cytological Diagnosis of Pancreatic Carcinoma
- Radiation therapy
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 3, 2020
Immunity to Infection in Healthy Participants and Cancer
Recruiting
- Influenza
- +3 more
- Biological sample collection
-
Tuebingen, Baden-Wuerttemberg, GermanyUniversity Hopsital Tuebingen
Mar 31, 2023
COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in
Not yet recruiting
- Follicular Lymphoma
- Cellular immunity vs SARS-CoV-2
- +6 more
-
Alessandria, IT, Italy
- +13 more
Oct 10, 2023
Non-Eosinophilic Biological Effects of IL-5
Not yet recruiting
- Asthma
- (no location specified)
Sep 6, 2023
Stage IIIA Hepatocellular Carcinoma Trial (Radiotherapy combined with TKI and Anti-PD-1 Antibody)
Not yet recruiting
- Stage IIIA Hepatocellular Carcinoma
- Radiotherapy combined with TKI and Anti-PD-1 Antibody
- (no location specified)
Sep 24, 2023
Gut Microbiome in Anti-tumor Therapy Induced Diarrhea
Recruiting
- Cancer
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
May 15, 2023
COVID-19 Trial in Vandœuvre-lès-Nancy (Generation of a biobank allowing the cryopreservation of leucocytes from COVID19
Not yet recruiting
- COVID-19
- Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors
-
Vandœuvre-lès-Nancy, Lorraine, FranceCHRU-Nancy - Hopitaux de Brabois - Batiment Philippe Canton
Aug 17, 2022
HIV, Yellow Fever Trial (Yellow fever vaccination (STAMARIL))
Not yet recruiting
- HIV Infections
- Yellow Fever
- Yellow fever vaccination (STAMARIL)
- (no location specified)
Jul 4, 2022
Healthy Subjects Trial in Charlottesville (Ultrasound stimulation intensity, Ultrasound stimulation site)
Recruiting
- Healthy Subjects
- Ultrasound stimulation intensity
- Ultrasound stimulation site
-
Charlottesville, VirginiaUniversity of Virginia, Division of Nephrology; Center for Immun
Jan 6, 2023
Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)
Completed
- Influenza
- Influenza Immunisation
- Influenza Virus Quadrivalent Inactivated Vaccine
-
Rochester, New YorkUniversity of Rochester Medical Center - Strong Memorial Hospita
Mar 17, 2022
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Covid19 Trial in New Brunswick (OL-1, standard dose, OL-1, high dose, Placebo)
Completed
- Covid19
- OL-1, standard dose
- +2 more
-
New Brunswick, New JerseyRutgers University
Jan 31, 2022
Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays
Not yet recruiting
- Lung Neoplasm
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023